Socioenvironmental Factors are Associated With Dopamine Transporter Availability in Healthy Individuals but not in Parkinson's Disease.

Parkinson’s disease dopamine transporter socioenvironmental factors

Journal

Journal of geriatric psychiatry and neurology
ISSN: 0891-9887
Titre abrégé: J Geriatr Psychiatry Neurol
Pays: United States
ID NLM: 8805645

Informations de publication

Date de publication:
07 Sep 2024
Historique:
medline: 8 9 2024
pubmed: 8 9 2024
entrez: 8 9 2024
Statut: aheadofprint

Résumé

Social factors can influence the brain's dopaminergic function. This study investigated the relationship between socioenvironmental factors and dopamine transporter (DaT) availability in healthy individuals (n = 74) and those with Parkinson's disease (PD) (n = 240). All single photon emission computed tomography (SPECT) DaT data and clinical data used in this study were obtained from the Parkinson's Progression Markers Initiative (PPMI) dataset. Socioenvironmental data was obtained from Social Explorer analyses of the American Community Survey (2014-2018) using the residential ZIP codes of the subjects available in the PPMI dataset. Participants resided in 302 ZIP code tabulation areas across 38 U.S. states. In healthy individuals The study findings suggest that socioenvironmental factors, such as median household income, education level, and poverty rate, are significantly associated with DaT availability in the caudate of healthy individuals but not in those with PD. This indicates that PD might disrupt the connection between the social environment and dopaminergic function. These results underscore the importance of considering socioenvironmental variables when studying dopaminergic function in the human brain.

Identifiants

pubmed: 39244698
doi: 10.1177/08919887241281062
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8919887241281062

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Salih Cayir (S)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.

Melike Tezel (M)

Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkiye.

David Matuskey (D)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.

Classifications MeSH